Chemoinformaics analysis of (2R)-1-[(2R)-Piperidin-2-yl]pentan-2-ol
Molecular Weight | 171.284 | nRot | 4 |
Heavy Atom Molecular Weight | 150.116 | nRig | 6 |
Exact Molecular Weight | 171.162 | nRing | 1 |
Solubility: LogS | -0.957 | nHRing | 1 |
Solubility: LogP | 1.692 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 21 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 32.6047 |
nHD | 2 | BPOL | 21.6373 |
QED | 0.674 |
Synth | 3.274 |
Natural Product Likeliness | 1.633 |
NR-PPAR-gamma | 0.008 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.999 |
HIA | 0.009 |
CACO-2 | -4.665 |
MDCK | 0.00000922 |
BBB | 0.719 |
PPB | 0.154954 |
VDSS | 1.231 |
FU | 0.798041 |
CYP1A2-inh | 0.072 |
CYP1A2-sub | 0.615 |
CYP2c19-inh | 0.042 |
CYP2c19-sub | 0.783 |
CYP2c9-inh | 0.006 |
CYP2c9-sub | 0.096 |
CYP2d6-inh | 0.058 |
CYP2d6-sub | 0.517 |
CYP3a4-inh | 0.014 |
CYP3a4-sub | 0.248 |
CL | 8.723 |
T12 | 0.458 |
hERG | 0.08 |
Ames | 0.01 |
ROA | 0.472 |
SkinSen | 0.94 |
Carcinogencity | 0.046 |
EI | 0.928 |
Respiratory | 0.94 |
NR-Aromatase | 0.01 |
Antiviral | No |
Prediction | 0.84429 |